OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.

Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.

Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.

Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.7 weeks; Submission to Acceptance: 17.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017
Open Access Interview

An Interview with Dr. Koh Iwasaki

OBM Geriatrics Editorial Office 

LIDSEN Publishing Inc., 2000 Auburn Drive, One Chagrin Highlands, Suite 200, Beachwood, OH, USA

Received: July 01, 2022 | Accepted: July 01, 2022 | Published: July 03, 2022

OBM Geriatrics 2022, Volume 6, Issue 3, doi:10.21926/obm.geriatr.2203201

Recommended citation: OBM Geriatrics Editorial Office. An Interview with Dr. Koh Iwasaki. OBM Geriatrics 2022; 6(3): 201; doi:10.21926/obm.geriatr.2203201.

© 2022 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Click to view original image

Dr. Koh Iwasaki

1. Could You Please Tell Us Your Scientific Background?

M.D., Ph.D. from Tohoku University, Japan.

2. Can You Share Your Career Development Story Briefly? For Example, What Cases Have Influenced You the Most?

When I was a medical school student, I got a chronic headache. NSAIDs were not effective. I visited a doctor who knew Kampo (Traditional Japanese Medicine) and he treated me with Kampo medicines. And my headache became much better. It is the first time I experienced Kampo and TCM.

When I entered the post graduate school of medicine at Tohoku university, the professor ordered me to find TCM improves aspiration pneumonia. I found that Banxia Houpu Tang (半夏厚朴湯)improved swallowing reflex [1].

And finally I proved that the TCM reduce the risk of aspiration pneumonia [2].

The work about 半夏厚朴湯 is one of my original works.

3. Is There a Book You’ve Read that You'd Recommend Universally (i.e., to Everyone You Meet)?

  1. 黄帝内经 (English edition https://www.amazon.com/ 黄帝内经 (英文版)-罗希文/dp/B00368BG42).

  2. 本草纲目(English edition https://www.amazon.com/Essentials-Chinese-Materia-Medica-Classics-ebook/dp/B07K2R2F7H/ref=sr_1_2?crid=2RTFXPT4BDK4J&keywords=本草纲目+English&qid=1654221663&sprefix=本草纲目)+english%2Caps%2C236&sr=8-2).

4. What is Your Main Research Area? What Got You Interested in Scientific Research in the First Place?

Geriatrics and TCM. Applying TCM for Geriatrics.

5. Where are Your Sources of Information? Where Do You Get Your Latest News about Geriatrics Research? Where Do You Take Inspiration From?

Daily practice.

6. What Is Your Long-Term Research Goal?

Applying TCM for Geriatric syndrome and frailty.

7. What Are the Recent Research Trends that You, as a Scholar, Would Suggest OBM Geriatrics to Observe and to Follow in the Coming Years?

Jia Wei Gui Pi Tang (Kamikihito, Kamiguibitang, 加味帰脾湯) for dementia.

8. Do You Have Any Suggestions or Recommendations for Young Scientists, for Instance, Your Students and Young Collaborators?

When I started my study applying TCM for geriatrics, 30 years ago, TCM was considered somewhat as a magic. Everyone refused to deal with me. But now, TCM has more than 100,000 English papers. If someone scoff you, never give up.

9. What Do You Think of the Future of OBM Geriatrics, an Open-Access Journal?

First of all, please get the position on PubMed again.


  1. Iwasaki K, Wang Q, Nakagawa T, Suzuki T, Sasaki H. The traditional Chinese medicine banxia houpo tang improves swallowing reflex. Phytomedicine. 1999; 6: 103-106. [CrossRef]
  2. Iwasaki K, Kato S, Monma Y, Niu K, Ohrui T, Okitsu R, et al. A pilot study of banxia houpu tang, a traditional Chinese medicine, for reducing pneumonia risk in older adults with dementia. J Am Geriatr Soc. 2007; 55: 2035-2040. [CrossRef]
Download PDF Download Citation
0 0